These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26634876)

  • 1. Stem cell transcription factor NANOG in cancers--is eternal youth a curse?
    Wong OG; Cheung AN
    Expert Opin Ther Targets; 2016; 20(4):407-17. PubMed ID: 26634876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of NANOG in cancer cells.
    Gong S; Li Q; Jeter CR; Fan Q; Tang DG; Liu B
    Mol Carcinog; 2015 Sep; 54(9):679-87. PubMed ID: 26013997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells.
    Huang ZJ; You J; Luo WY; Chen BS; Feng QZ; Wu BL; Jiang L; Luo Q
    Mol Med Rep; 2015 Mar; 11(3):1647-54. PubMed ID: 25405855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
    Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
    J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concise Review: NANOG in Cancer Stem Cells and Tumor Development: An Update and Outstanding Questions.
    Jeter CR; Yang T; Wang J; Chao HP; Tang DG
    Stem Cells; 2015 Aug; 33(8):2381-90. PubMed ID: 25821200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NANOG Metabolically Reprograms Tumor-Initiating Stem-like Cells through Tumorigenic Changes in Oxidative Phosphorylation and Fatty Acid Metabolism.
    Chen CL; Uthaya Kumar DB; Punj V; Xu J; Sher L; Tahara SM; Hess S; Machida K
    Cell Metab; 2016 Jan; 23(1):206-19. PubMed ID: 26724859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma.
    Shan J; Shen J; Liu L; Xia F; Xu C; Duan G; Xu Y; Ma Q; Yang Z; Zhang Q; Ma L; Liu J; Xu S; Yan X; Bie P; Cui Y; Bian XW; Qian C
    Hepatology; 2012 Sep; 56(3):1004-14. PubMed ID: 22473773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of ZFX confers self-renewal and chemoresistance properties in hepatocellular carcinoma.
    Lai KP; Chen J; He M; Ching AK; Lau C; Lai PB; To KF; Wong N
    Int J Cancer; 2014 Oct; 135(8):1790-9. PubMed ID: 24585547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tricostantin A inhibits self-renewal of breast cancer stem cells in vitro].
    Peng L; Li FX; Shao WF; Xiong JB
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1421-6. PubMed ID: 24144739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NANOG: a promising target for digestive malignant tumors.
    Sun AX; Liu CJ; Sun ZQ; Wei Z
    World J Gastroenterol; 2014 Sep; 20(36):13071-8. PubMed ID: 25278701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of NANOG enhances chemosensitivity of liver cancer cells to doxorubicin by reducing MDR1 expression.
    Zhou JJ; Deng XG; He XY; Zhou Y; Yu M; Gao WC; Zeng B; Zhou QB; Li ZH; Chen RF
    Int J Oncol; 2014 Jun; 44(6):2034-40. PubMed ID: 24647772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma.
    Tsai LL; Yu CC; Chang YC; Yu CH; Chou MY
    J Oral Pathol Med; 2011 Sep; 40(8):621-8. PubMed ID: 21342274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The oncogenic potential of NANOG: An important cancer induction mediator.
    Najafzadeh B; Asadzadeh Z; Motafakker Azad R; Mokhtarzadeh A; Baghbanzadeh A; Alemohammad H; Abdoli Shadbad M; Vasefifar P; Najafi S; Baradaran B
    J Cell Physiol; 2021 Apr; 236(4):2443-2458. PubMed ID: 32960465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into the
    Zhang W; Sui Y; Ni J; Yang T
    Int J Biol Sci; 2016; 12(11):1372-1381. PubMed ID: 27877089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of NANOG transcriptional factor in the development of malignant phenotype of cancer cells.
    Gawlik-Rzemieniewska N; Bednarek I
    Cancer Biol Ther; 2016; 17(1):1-10. PubMed ID: 26618281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of human growth and differentiation factor 3 gene expression by NANOG in human embryonic carcinoma NCCIT cells.
    Park SW; Lim HY; Do HJ; Sung B; Huh SH; Uhm SJ; Song H; Chung HJ; Kim JH; Kim NH; Kim JH
    FEBS Lett; 2012 Sep; 586(19):3529-35. PubMed ID: 22963770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signaling pathways and microRNAs, the orchestrators of NANOG activity during cancer induction.
    Alemohammad H; Asadzadeh Z; Motafakker Azad R; Hemmat N; Najafzadeh B; Vasefifar P; Najafi S; Baradaran B
    Life Sci; 2020 Nov; 260():118337. PubMed ID: 32841661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanog regulates molecules involved in stemness and cell cycle-signaling pathway for maintenance of pluripotency of P19 embryonal carcinoma stem cells.
    Choi SC; Choi JH; Park CY; Ahn CM; Hong SJ; Lim DS
    J Cell Physiol; 2012 Nov; 227(11):3678-92. PubMed ID: 22378194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of E-cadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancers.
    Siu MK; Wong ES; Kong DS; Chan HY; Jiang L; Wong OG; Lam EW; Chan KK; Ngan HY; Le XF; Cheung AN
    Oncogene; 2013 Jul; 32(30):3500-9. PubMed ID: 22945654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Nanog expression promotes tumor development and Cisplatin resistance in human esophageal cancer cells.
    Yang L; Zhang X; Zhang M; Zhang J; Sheng Y; Sun X; Chen Q; Wang LX
    Cell Physiol Biochem; 2012; 30(4):943-52. PubMed ID: 23221432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.